QuantiFERON–CMV is not available in the United States.
QuantiFERON–CMV is CE marked for commercial use in Europe

Search Results: Displaying all items (8)

First Author Title Journal Publication Date
Bono P. Quantiferon CMV assay in allogenic stem cell transplant patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016
Fernández-Ruiz M. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clinical & translational immunology 2014
Torre-Cisneros J. Toward the individualization of cytomegalovirus control after solid-organ transplantation: the importance of the "individual pathogenic balance". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009
Kotton CN. Management of cytomegalovirus infection in solid organ transplantation. Nature reviews. Nephrology 2010
Weclawiak H. [Cytomegalovirus effects in solid organ transplantation and the role of antiviral prophylaxis]. Néphrologie & thérapeutique 2010
Cantisán Bohórquez S. [Immunological monitoring strategies for cytomegalovirus infection. Immune-based therapies]. Enfermedades infecciosas y microbiología clínica 2011
Kumar D. Cytomegalovirus prophylaxis: how long is enough? Nature reviews. Nephrology 2010
Danziger-Isakov L. Clinical utility of measuring T-cell immunity to CMV in transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009